Showing 1301-1310 of 1517 results for "".
Isotretinoin: Expanding Access to Improve Outcomes
https://practicaldermatology.com/topics/acne-rosacea/isotretinoin-expanding-access-to-improve-outcomes/22961/A new pharmacy service program seeks to support patient education, streamline testing, and expedite access to isotretinoin—taking responsibility off of practices.New Frontiers in Neurotoxins
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-frontiers-in-neurotoxins/21638/Recent innovations offer patients greater variety and potentially better outcomes.Adjusting to a Paradigm Shift in Documentation
https://practicaldermatology.com/topics/practice-management/adjusting-to-a-paradigm-shift-in-documentation/21681/Clinicians can navigate changing rules by selecting technologies that accommodate rapid shifts in documentation.Therapeutics Update
https://practicaldermatology.com/topics/psoriasis/therapeutics-update/20530/New products and pharmacologic developmentsPRP: Assessing Its Safety and Efficacy
https://practicaldermatology.com/topics/practice-management/prp-assessing-its-safety-and-efficacy/20580/As use of platelet-rich plasma grows in popularity, a dermatologist undertakes a review of the current evidence.“S or “C” Corporation for Your Practice
https://practicaldermatology.com/topics/practice-management/s-or-c-corporation-for-your-practice/21503/Maximize tax deductions by using both.Cosmetic Dermatology: Ensuring Success at Any Level
https://practicaldermatology.com/topics/general-topics/PD0409_02-php/22840/In practice and perspective, a balanced approach to cosmetic and medical affairs coupled with a strong team ensures effective implementation of cosmetic services.New Tool Helps Patients Select Safe Skincare
https://practicaldermatology.com/topics/atopic-dermatitis/new-tool-helps-patients-select-safe-skincare/23447/SkinSAFE cuts through the phenomenon of sensitive skin for consumers and dermatologists.Prurigo Nodularis: An Update for Clinicians, Part 1
https://practicaldermatology.com/topics/general-topics/prurigo-nodularis-an-update-for-clinicians-part-1/20507/Here's a look at the diagnosis of an “eczematous” condition with an unclear etiology.Pipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.